Prothrombin has been altered in patients receiving Sterile Ceftriaxone Sodium.
Hypersensitivity to Cephalosporins and/or penicillins should be looked before starting Sterile Ceftriaxone Sodium.
Sterile Ceftriaxone Sodium should be given with caution in patients with gastrointestinal disease especially colitis.
The drug should be discontinued in patients showing evidence of gall bladder disease or sonographic abnormalities.
Carcinogenicity: Specific studies to determine the carcinogenic potential of Sterile Ceftriaxone Sodium have not been performed to date and animal toxicity studies have been performed to a maximum duration of 6 months.